The impact of body weight management in chronic kidney disease patients with obesity

Journal of Renal Nutrition

Volumn 23, Issue 5, 2013, Pages 372-379

  Wang, Ya Ling ^a   Shu, Kuo Hsiung ^a,b   Yang, Mei Fang ^a   Yang, Wen Ching ^a   Wu, Ming Ju ^a,b   Lin, Tzu Mei ^a   Chen, Cheng Hsu ^a,b,c,d  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TUNGHAI UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; LIPID;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CHRONIC KIDNEY FAILURE; DIET; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY; LIFESTYLE; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; PATHOPHYSIOLOGY; PROTEINURIA; TAIWAN; YOUNG ADULT;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; CREATININE; DIET; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LIFE STYLE; LIPIDS; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; TAIWAN; YOUNG ADULT;

EID: 84882879148     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2013.04.004     Document Type: Article

References (30)

1. Flegal K.M., Carroll M.D., Kuczmarski R.J., Johnson C.L. Overweight and obesity in the United States: Prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998, 22:39-47.
2. Chu N.F. Prevalence of obesity in Taiwan. Obes Rev 2005, 6:271-274.
3. The Prevalence of Overweight and Obesity in General Population with Age over 18 in Taiwan from 2008 to 2010 2011, Bureau of Health Promotion, Department of Health, Taipei, Taiwan.
4. Weisinger J.R., Kempson R.L., Eldridge F.L., Swenson R.S. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 1974, 81:440-447.
5. Kasiske B.I., Crosson J.T. Renal disease in patients with massive obesity. Arch Intern Med 1986, 146:1105-1109.
6. Kasiske B.L., Napier J. Glomerular sclerosis in patients with massive obesity. Am J Nephrol 1985, 5:45-50.
7. Verani R.R. Obesity-associated focal segmental glomerulosclerosis: pathological feature of the lesion and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis 1992, 20:629-634.
8. Henegar J.R., Bigler S.A., Henegar L.K., et al. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001, 12:1211-1217.
9. Praga M., Morales E. Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens 2006, 15:481-486.
10. Kramer H., Luke A. Obesity and kidney disease: a big dilemma. Curr Opin Nephrol Hypertens 2007, 16:237-241.
11. Schena F.P. Management of patients with chronic kidney disease. Intern Emerg Med 2011, 6(suppl 1):S77-S83.
12. Peralta C.A., Kurella M., Lo J.C., et al. The metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 2006, 15:361-365.
13. Weiss R., Dziura J., Burgert T.S., et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004, 350:2362-2374.
14. Stump C.S. Physical activity in the prevention of chronic kidney disease. Cardiorenal Med 2011, 1:164-173.
15. Navaneethan S.D., Kirwan J.P., Arrigain S., Schreiber M.J., Sehgal A.R., Schold J.D. Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006. Int J Obes (Lond) 2012, 36:1585-1590.
16. Liu K., Ruth K.J., Flack J.M., et al. Blood pressure in young blacks and whites: relevance of obesity and lifestyle factors in determining differences. The CARDIA Study. Coronary Artery Risk Development in Young Adults. Circulation 1996, 93:60-66.
17. Wilson P.W., D'Agostino R.B., Sullivan L., Parise H., Kannel W.B. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002, 162:1867-1872.
18. Meng X.J., Dong G.H., Wang D., et al. Epidemiology of prehypertension and associated risk factors in urban adults from 33 communities in China. Circ J 2012, 76:900-906.
19. Chan J.M., Rimm E.B., Colditz G.A., Stampfer M.J., Willett W.C. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994, 17:961-969.
20. Gyebi L., Soltani Z., Reisin E. Lipid nephrotoxicity: new concept for an old disease. Curr Hypertens Rep 2012, 14:177-181.
21. Sowers J.R., Whaley-Connell A., Hayden M.R. The role of overweight and obesity in the cardiorenal syndrome. Cardiorenal Med 2011, 1:5-12.
22. National Heart, Lung, and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults 1998, National Heart, Lung and Blood Institute, Bethesda, MD.
23. Ohashi H., Oda H., Ohno M., et al. Weight reduction improves high blood pressure and microalbuminuria in hypertensive patients with obesity. Nippon Jinzo Gakkai Shi 2001, 43:333-339.
24. Praga M., Hernandez E., Herrero J.C., et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 2000, 58:2111-2118.
25. Vasquez B., Flock E.V., Savage P.J., et al. Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia. Diabetologia 1984, 26:127-133.
26. Solerte S.B., Fioravanti M., Schifino N., Ferrari E. Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy. Int J Obes 1989, 13:203-211.
27. Chana R.S., Wheeler D.C., Thomas G.J., Williams J.D., Davies M. Low-density lipoprotein stimulates mesangial cell proteoglycan and hyaluronan synthesis. Nephrol Dial Transpl 2000, 15:167-172.
28. Chen G., Paka L., Kako Y., Singhal P., Duan W., Pillarisetti S. A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion. J Biol Chem 2001, 276:49142-49147.
29. Moorhead J.F., Chan M.K., El-Nahas M., Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982, 2:1309-1311.
30. Hosten A.O. BUN and creatinine. Source Clinical Methods: The History, Physical, and Laboratory Examinations 1990, 874-878. Butterworths, Boston, MA. 3rd ed. H.K. Walker, W.D. Hall, J.W. Hurst (Eds.).